Drug Name:
METANX Rx
Generic Name and Formulations:
L-methylfolate calcium (as Metafolin) 3mg, Algae-S powder (Schizochytrium) 90.314mg, pyridoxal 5'-phosphate 35mg, methylcobalamin 2mg; caps.
Company:
Alfasigma USA, Inc.
Therapeutic Use:
Indications for METANX:
Clinical dietary management of diabetic peripheral neuropathy.
Adult:
Use only under medical supervision. 1 cap twice daily or 2 caps once daily.
Children:
Not recommended.
Warnings/Precautions:
Folic acid may mask Vit.B12 deficiency, including pernicious anemia.
Pharmacological Class:
Medical food.
Adverse Reactions:
Acne, skin reactions, allergic reactions, photosensitivity, nausea, vomiting, abdominal pain, loss of appetite, increased LFTs, paresthesia, somnolence, headache, mild transient diarrhea, itching, transitory exanthema, feeling of body swelling.
Elimination:
Renal.
Generic Availability:
YES
How Supplied:
Caps—90, 180
Clinical Pain Advisor Articles
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Set of Personality Traits May Predict Prescription Drug Use, Misuse in Young Adults
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Predicting Pain Chronicization After Spine Surgery
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Medicaid Expansion Under the ACA Increased Access to Opioid Use Disorder Treatments
- DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019
- Survey Says: Perspectives From Women in Health Care
- Butalbital/APAP Capsules Launched for Complex Tension Headache
- Concomitant Use of Pregabalin and Opioids May Increase Risk for Opioid-Related Death
